Industry Average Yield: 2.22 %
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio | |
|---|---|---|---|---|---|---|---|
 |
NVS | Novartis | 2.07 % | 181 B | 3.9 % | 34.84 | |
 |
MRK | Merck | 3.59 % | 200 B | 3.1 % | 29.49 | |
 |
JNJ | Johnson & Johnson | 2.90 % | 419 B | 2.8 % | 24.30 | |
 |
BMY | Bristol-Myers Squibb | 4.17 % | 126 B | 3.7 % | -24.41 | |
 |
GSK | GlaxoSmithKline | 4.01 % | 101 B | 4.4 % | 16.79 | |
 |
LLY | Eli Lilly | 1.92 % | 249 B | 1.0 % | 41.59 | |
 |
ZTS | Zoetis | 1.75 % | 104 B | 0.9 % | 51.76 | |
 |
AZN | AstraZeneca | 2.33 % | 176 B | 2.2 % | 48.07 | |
 |
PFE | Pfizer | 3.29 % | 303 B | 5.2 % | 21.08 | |
 |
PRGO | Perrigo | 2.83 % | 5 B | 3.2 % | -16.58 | |
 |
AGN | Allergan | • | 64 B | 1.8 % | • | |
 |
TEVA | Teva Pharmaceutical Industries | • | 10 B | 3.0 % | 14.45 | |
 |
TARO | Taro Pharmaceutical Industries | • | 2 B | 12.3 % | 0.00 |
Industry Average Yield: •
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio |
|---|
Industry Average Yield: 4.45 %
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio | |
|---|---|---|---|---|---|---|---|
 |
PAHC | Phibro Animal Health | 2.45 % | 843 M | 2.7 % | 8.05 | |
 |
SNY | Sanofi | 4.28 % | 123 B | • | 8.19 | |
|
PRPH | ProPhase Labs | 6.63 % | 94 M | 27.1 % | 0.00 |
Industry Average Yield: 0.87 %
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio | |
|---|---|---|---|---|---|---|---|
|
0O59 | Sanofi | 4.26 % | 123 B | 1.6 % | 0.00 | |
|
0QAH | Merck | 3.61 % | 200 B | • | 25.49 | |
|
0QLR | Novartis | 0.04 % | 181 B | 0.0 % | 0.00 | |
|
GSK | GlaxoSmithKline | 0.03 % | 101 B | 11.8 % | 0.00 | |
 |
HIK | Hikma Pharmaceuticals | 0.07 % | 7 B | 7.1 % | 0.00 | |
|
AZN | AstraZeneca | 0.02 % | 176 B | • | 0.00 | |
|
0Q1G | Eli Lilly | 0.01 % | 249 B | 0.0 % | 36.00 | |
|
0O14 | Merck | 1.33 % | 200 B | 0.6 % | 0.00 | |
|
EAH | ECO Animal Health | 0.01 % | 137 M | 2.0 % | 0.00 | |
 |
DPH | Dechra Pharmaceuticals | 0.02 % | 7 B | 68.5 % | 0.00 | |
 |
VEC | Vectura | 0.12 % | 1 B | 7.0 % | 0.00 |
Industry Average Yield: •
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio |
|---|
Industry Average Yield: 1.90 %
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio | |
|---|---|---|---|---|---|---|---|
|
4540 | Tsumura | 3.85 % | 2 B | 2.5 % | 0.00 | |
|
4548 | Seikagaku | 2.04 % | 485 M | 2.8 % | 0.00 | |
|
4547 | Kissei Pharmaceutical | 1.28 % | 896 M | 2.6 % | 0.00 | |
 |
4151 | Kyowa Kirin | 2.39 % | 16 B | 1.9 % | 0.00 | |
|
4521 | Kaken Pharmaceutical | 2.29 % | 1 B | 3.9 % | 0.00 | |
 |
4519 | Chugai Pharmaceutical | 2.05 % | 57 B | 1.7 % | 0.00 | |
|
4577 | Daito Pharmaceutical | 4.20 % | 339 M | 1.9 % | 0.00 | |
|
4559 | Zeria Pharmaceutical | 1.09 % | 791 M | 1.9 % | 0.00 | |
|
4553 | Towa Pharmaceutical | 0.98 % | 1 B | 2.2 % | 0.00 | |
|
4527 | Rohto Pharmaceutical | 0.88 % | 3 B | 1.1 % | 0.00 | |
|
4538 | Fuso Pharmaceutical Industries | 1.88 % | 191 M | 3.2 % | 0.00 | |
|
4503 | Astellas Pharma | 1.52 % | 31 B | 3.6 % | 0.00 | |
|
4578 | Otsuka | 1.44 % | 20 B | 2.0 % | 0.00 | |
 |
4502 | Takeda Pharmaceutical | 3.50 % | 44 B | 4.6 % | 0.00 | |
|
4530 | Hisamitsu Pharmaceutical | 1.08 % | 3 B | 1.3 % | 0.00 | |
|
4528 | Ono Pharmaceutical | 3.18 % | 11 B | 2.9 % | 0.00 | |
 |
4568 | Daiichi Sankyo | 2.77 % | 45 B | 1.1 % | 0.00 | |
|
4536 | Santen Pharmaceutical | 1.08 % | 5 B | 2.4 % | 0.00 | |
|
4574 | Taiko Pharmaceutical | 2.54 % | 297 M | 0.7 % | 0.00 | |
|
4534 | Mochida Pharmaceutical | 1.11 % | 1 B | 2.4 % | 0.00 | |
|
4554 | Fuji Pharma | 0.93 % | 236 M | 2.9 % | 0.00 | |
|
4506 | Sumitomo Dainippon Pharma | 2.53 % | 5 B | 1.5 % | 0.00 | |
|
4516 | Nippon Shinyaku | 1.20 % | 5 B | 2.2 % | 0.00 | |
|
4569 | KYORIN | 3.45 % | 864 M | 3.2 % | 0.00 | |
|
4552 | JCR Pharmaceuticals | 1.74 % | 3 B | 1.8 % | 0.00 | |
|
4523 | Eisai | 3.28 % | 18 B | 2.5 % | 0.00 | |
|
4541 | Nichi-Iko Pharmaceutical | 2.59 % | 439 M | 2.1 % | 0.00 | |
|
4539 | Nippon Chemiphar | • | 68 M | 2.8 % | 0.00 | |
|
4581 | Taisho Pharmaceutical | 1.16 % | 4 B | 1.5 % | 0.00 | |
 |
4507 | Shionogi | 0.95 % | 22 B | 1.9 % | 0.00 | |
|
4512 | Wakamoto Pharmaceutical | • | 91 M | 1.2 % | 0.00 |
Industry Average Yield: •
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio |
|---|
Industry Average Yield: 2.16 %
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio | |
|---|---|---|---|---|---|---|---|
|
LLY | Eli Lilly | 1.73 % | 249 B | • | 34.39 | |
|
PFE | Pfizer | 2.97 % | 303 B | 4.6 % | 13.65 | |
|
MRK | Merck | 1.33 % | 200 B | 1.3 % | 0.00 | |
|
JNJ | Johnson & Johnson | 2.61 % | 419 B | • | 21.73 |
Industry Average Yield: 2.17 %
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio | |
|---|---|---|---|---|---|---|---|
|
LLY | Eli Lilly | 1.74 % | 249 B | • | 34.58 | |
|
MRK | Merck | 1.33 % | 200 B | 1.3 % | 0.00 | |
|
PFE | Pfizer | 2.98 % | 303 B | 5.0 % | 13.56 | |
|
JNJ | Johnson & Johnson | 2.63 % | 419 B | • | 21.57 |
Industry Average Yield: •
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio |
|---|
Industry Average Yield: •
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio |
|---|
Industry Average Yield: •
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio |
|---|
Industry Average Yield: •
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio |
|---|
Industry Average Yield: •
Calculated as the simple average of the dividend yields of a company in this group.
| Ticker | Company | Div.Rating | Dividend Yield | Market Capitalization | Average Yield, 5y | P/E ratio |
|---|
Dividends represent one part of the company’s profits from the previous period. The company distributes them between its owner-shareholders. Businesses may pay out dividends, but they are not obliged to. The method that is used to calculate the dividend is described in the company's dividend policy or articles of association. The clearer and more transparent the calculation principle, the more investors love the company. Many factors affect whether dividends are paid out. The main ones are the need for financing by major shareholders and tax optimization. So, if the state in the person of a fund or state-supported organization is one of the shareholders, the payment of regular dividends is practically guaranteed. The same is true, but to a lesser extent, in the case of a serious debt burden that is incurred by one of the business owners.